title: Pharmacologic treatment of hyperthyroidism during lactation.
abstract: OBJECTIVE
  I have a patient who has hyperthyroidism due to Graves disease. She was taking methimazole but discontinued when she found out she was pregnant. She is currently close to delivery and might require antithyroid therapy in the postpartum period. Can methimazole cross into human milk, and is breastfeeding safe for her infant?
  
  
  CONCLUSIONS
  The exposure of infants to methimazole or propylthiouracil through breast milk is minimal and not clinically significant. Women with hyperthyroidism using methimazole or propylthiouracil should not be discouraged from breastfeeding, as the benefits of breastfeeding largely outweigh the theoretical minimal risks.
authors.forename: Miguel Marcelo
authors.initials: MM
authors.lastname: Glatstein
authors.forename: Facundo
authors.initials: F
authors.lastname: Garcia-Bournissen
authors.forename: Norberto
authors.initials: N
authors.lastname: Giglio
authors.forename: Yaron
authors.initials: Y
authors.lastname: Finkelstein
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D013956:Antithyroid Agents / Q000009:adverse effects / Q000032:analysis*; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D007774:Lactation; D018811:Maternal Exposure; D008713:Methimazole / Q000009:adverse effects / Q000032:analysis* / Q000627:therapeutic use; D008895:Milk, Human / Q000737:chemistry*; D011247:Pregnancy; D011441:Propylthiouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis*; D013961:Thyroid Gland / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil
references.citation: Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:124-33
references.pmid: 16456491
references.citation: J Clin Endocrinol Metab. 1975 Jan;40(1):26-9
references.pmid: 1112878
references.citation: Nihon Rinsho. 2006 Dec;64(12):2297-302
references.pmid: 17154095
references.citation: Pharmacology. 1982;25(1):57-60
references.pmid: 7122691
references.citation: Ann Pharmacother. 2003 Jul-Aug;37(7-8):1100-9
references.pmid: 12841824
references.citation: J Pediatr Endocrinol Metab. 2003 Dec;16(9):1239-43
references.pmid: 14714745
references.citation: Acta Endocrinol (Copenh). 1983 Aug;103(4):509-20
references.pmid: 6613495
references.citation: N Engl J Med. 2005 Mar 3;352(9):905-17
references.pmid: 15745981
references.citation: Arq Gastroenterol. 2000 Apr-Jun;37(2):129-32
references.pmid: 11144016
references.citation: Lancet. 1979 Nov 10;2(8150):1011
references.pmid: 91730
references.citation: Clin Endocrinol (Oxf). 1984 Jul;21(1):81-7
references.pmid: 6744638
references.citation: J Pharmacol Exp Ther. 2008 Mar;324(3):1037-44
references.pmid: 18055877
references.citation: N Engl J Med. 2000 Jul 13;343(2):118-26
references.pmid: 10891521
references.citation: Drugs. 1998 Apr;55(4):543-53
references.pmid: 9561343
references.citation: J Pediatr. 1996 Jun;128(6):855-8
references.pmid: 8648549
references.citation: Am J Med Genet. 1999 Mar 5;83(1):43-6
references.pmid: 10076883
references.citation: Am J Obstet Gynecol. 1987 Aug;157(2):234-5
references.pmid: 2441601
references.citation: Endocrinology. 1978 Sep;103(3):871-82
references.pmid: 744122
references.citation: Klin Wochenschr. 1985 Dec 2;63(23):1212-7
references.pmid: 3841378
references.citation: Clin Endocrinol (Oxf). 2000 Aug;53(2):177-81
references.pmid: 10931098